Pfizer Moves To Quell EU Concerns On $17B Hospira Deal
New York-based pharmaceutical company Pfizer Inc. has offered concessions to European antitrust regulators in an attempt to push through a $17 billion takeover of injectables and biosimilars giant Hospira Inc., the...To view the full article, register now.
Already a subscriber? Click here to view full article